These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Endothelin and essential hypertension]. Kobusiak-Prokopowicz M Pol Merkur Lekarski; 2002 Jan; 12(67):65-8. PubMed ID: 11957808 [TBL] [Abstract][Full Text] [Related]
4. [The role and clinical importance of nitric oxide-endothelin system in hypertension]. Katona E; Juhász M; Varga Z; Paragh G; Fülesdi B; Páll D Orv Hetil; 2006 Sep; 147(38):1819-24. PubMed ID: 17066598 [TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in human disease. Drexler H; Hornig B J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715 [TBL] [Abstract][Full Text] [Related]
7. [Endothelial dysfunction in hypertension--clinical implications]. Kosmala W Pol Merkur Lekarski; 2002 Apr; 12(70):333-5. PubMed ID: 12089901 [TBL] [Abstract][Full Text] [Related]
8. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Amiri F; Virdis A; Neves MF; Iglarz M; Seidah NG; Touyz RM; Reudelhuber TL; Schiffrin EL Circulation; 2004 Oct; 110(15):2233-40. PubMed ID: 15466627 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions. Bauer V; Sotníková R Gen Physiol Biophys; 2010 Dec; 29(4):319-40. PubMed ID: 21156995 [TBL] [Abstract][Full Text] [Related]
10. [Endothelial dysfunction]. Nagy J; Csiky B; Kovács T; Wittmann I Orv Hetil; 2001 Aug; 142(31):1667-72. PubMed ID: 11556260 [TBL] [Abstract][Full Text] [Related]
11. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells. Warner TD Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631 [TBL] [Abstract][Full Text] [Related]
16. Local mechanisms of blood flow control by perivascular nerves and endothelium. Burnstock G J Hypertens Suppl; 1990 Dec; 8(7):S95-106. PubMed ID: 1982771 [TBL] [Abstract][Full Text] [Related]
17. Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications. Rongen GA; Smits P; Thien T Neth J Med; 1994 Jan; 44(1):26-35. PubMed ID: 8202203 [TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. Matsumoto T; Nakayama N; Ishida K; Kobayashi T; Kamata K J Pharmacol Exp Ther; 2009 Apr; 329(1):324-34. PubMed ID: 19164460 [TBL] [Abstract][Full Text] [Related]
19. [Endothelial dysfunction and vascular pathology]. Vanhoutte PM Bull Mem Acad R Med Belg; 2006; 161(10-12):529-36; discussion 536-7. PubMed ID: 17503729 [TBL] [Abstract][Full Text] [Related]
20. Biosynthesis and interaction of endothelium-derived vasoactive mediators. Thiemermann C Eicosanoids; 1991; 4(4):187-202. PubMed ID: 1789995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]